Matthew Weinberg Writes for International Clinical Trials (ICT) Magazine

August 16, 2013

In this article CEO Matthew Weinberg discusses the downsides to self-auditing good clinical practice and the need smaller, more proactive audits, on the other hand, can provide a more intelligent analysis.

TAGS:

Related Articles

Company News

December 15, 2020

Mydecine Innovations Group Engages ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials

DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research,...

Continue reading the blog post

February 11, 2014

Drug Companies Face Stricter Clinical Trial Regulation Worldwide

For more information on The Weinberg Group’s independent clinical auditing services, please contact Jeff Antos at jeff.antos@weinberggroup.com or 202.280.0815.

Continue reading the blog post
ProPharma honored by Clinical Trials Arena with two awards
Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma has been recognized as a dual-category winner in the Clinical Trial Arena Excellence Awards, receiving accolades in both Business Expansion and Mergers & Acquisitions (M&A). These awards...

Continue reading the blog post